focus -WSS

focus

author：hotspot 2025-10-02 20:06:19 - browse：476

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Cheap, fast test for Zika and dengue could cost just $1

entertainment

WSS

Scientists grapple with ethics of stem cell research

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Judge denies Trump's request for new trial in E. Jean Carroll case

Delta passengers in Vegas fall sick while waiting on flight in triple

hotspot

focus

hotspot

New air purifier tech could be key to improving indoor air quality

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

State Dept. review finds Biden bears some blame for Afghanistan failures

ALS patient reclaims some autonomy thanks to wearable 'robot'

ChatGPT in medicine: STAT answers readers' burning questions

How faith leaders like me can help address America's obesity epidemic

In age of alternative facts, a scholarly course on calling out crap

5 takeaways from STAT's examination of Zynex Medical

Jerome Adams on the need for new antivirals for Covid

Mystery swirls around US soldier who entered North Korea days ago, officials say

leisure time

5 takeaways from STAT's examination of Zynex Medical

The stock market has soared this year, but will it last? Experts weigh in

Pharma companies must ensure equitable access to obesity drugs

Report captures long Covid’s disabling effects and policy challenges

NIH tests clinical research in primary care with $30 million program

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

focus

entertainment

hotspot

focus